These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30892185)

  • 1. A Large Gray-Blue Macule on the Hard Palate as an Adverse Effect of Imatinib.
    Lueken N; Kaune KM; Zutt M
    Dtsch Arztebl Int; 2019 Feb; 116(6):95. PubMed ID: 30892185
    [No Abstract]   [Full Text] [Related]  

  • 2. Mucosal pigmentation of the hard palate in a patient taking imatinib.
    Lyne A; Creedon A; Bailey BM
    BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25883257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imatinib-induced diffuse hyperpigmentation of the oral mucosa, the skin, and the nails in a patient affected by chronic myeloid leukemia: report of a case and review of the literature.
    Di Tullio F; Mandel VD; Scotti R; Padalino C; Pellacani G
    Int J Dermatol; 2018 Jul; 57(7):784-790. PubMed ID: 29417559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperpigmentation of the hard palate associated with imatinib therapy for chronic myeloid leukemia with a genetic variation in the proto-oncogene c-KIT.
    Khoo TL; Catalano A; Supple S; Chong L; Yeoh SC; Yeung S; Iland H
    Leuk Lymphoma; 2013 Jan; 54(1):186-8. PubMed ID: 22712835
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of oral mucosa hyperpigmentation with imatinib mesylate use: a cross-sectional study and a systematic literature review.
    Oliveira SR; de Azevedo Branco LG; Rocha AL; Travassos DV; Magalhães GHR; Fonseca FP; Mesquita RA; Abreu LG; da Silva TA
    Clin Oral Investig; 2019 Dec; 23(12):4371-4382. PubMed ID: 30968242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blue palate-A case series of imatinib-related oral pigmentation and literature review.
    Donnell CC; Walton RL; Carrozzo M
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Jan; 131(1):49-61. PubMed ID: 33199217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib mesylate-induced pseudoporphyria in a patient with chronic myeloid leukemia.
    Batrani M; Salhotra M; Kubba A; Agrawal M
    Indian J Dermatol Venereol Leprol; 2016; 82(6):727-729. PubMed ID: 27716725
    [No Abstract]   [Full Text] [Related]  

  • 8. Squamous cell carcinoma in a chronic myelogenous leukemia patient treated with imatinib mesylate.
    Fujii M; Iwasaki T; Takahashi I; Kishiyama K; Honma M; Takahashi H; Ishida-Yamamoto A; Iizuka H
    J Dermatol; 2015 Mar; 42(3):338-9. PubMed ID: 25580575
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term mucocutaneous adverse effects of imatinib in Indian chronic myeloid leukemia patients.
    Vinay K; Yanamandra U; Dogra S; Handa S; Suri V; Kumari S; Khadwal A; Prakash G; Lad D; Varma S; Malhotra P
    Int J Dermatol; 2018 Mar; 57(3):332-338. PubMed ID: 29266186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous adverse reaction to imatinib in a case of childhood chronic myeloid leukemia.
    Saroha M
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28490. PubMed ID: 32573963
    [No Abstract]   [Full Text] [Related]  

  • 11. Imatinib mesylate- and dasatinib-induced eosinophilia in a patient with chronic myelocytic leukemia.
    McGrath K; Stein B; Kalhagen L; Leighton L
    Ann Allergy Asthma Immunol; 2017 Jul; 119(1):85-86. PubMed ID: 28499700
    [No Abstract]   [Full Text] [Related]  

  • 12. Imatinib-induced pseudoporphyria.
    Martinez-Mera C; Capusan TM; Herrero-Moyano M; Urquía Renke A; Steegmann Olmedillas JL; de Argila D
    Clin Exp Dermatol; 2018 Jun; 43(4):463-466. PubMed ID: 29315788
    [No Abstract]   [Full Text] [Related]  

  • 13. Cystic acne due to imatinib therapy for chronic myelocytic leukemia.
    Hwang A; Iskandar A; Del Rosario M; Dasanu CA
    J Oncol Pharm Pract; 2019 Jun; 25(4):972-974. PubMed ID: 29498323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Imatinib-induced pigmentation of the hard palate].
    Kluger N; Cassier P; Ruffion N
    Ann Dermatol Venereol; 2018 Nov; 145(11):723-724. PubMed ID: 30472997
    [No Abstract]   [Full Text] [Related]  

  • 15. Imatinib mesylate induced erythroderma: A rare case series.
    Kumar S; Mahajan BB; Kaur S; Banipal RP; Singh A
    J Cancer Res Ther; 2015; 11(4):993-6. PubMed ID: 26881566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imatinib-Associated Pneumocystis jirovecii Pneumonia in a Patient With Chronic Myeloid Leukemia.
    Daw J; Thapa B; Chahine J; Lak H; Perez O; Nair R; Alomari M; Haddad A
    Am J Ther; 2020; 27(4):e406-e409. PubMed ID: 31356343
    [No Abstract]   [Full Text] [Related]  

  • 17. Second primary malignancies in chronic myeloid leukemia patients.
    Caliskan T; Eskazan AE
    J Cancer Res Ther; 2015; 11(4):1042. PubMed ID: 26881669
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute generalized exanthematous pustulosis (AGEP) secondary to imatinib in a patient with chronic myeloid leukaemia.
    Scott AD; Lee M; Kubba F; Chu A
    Clin Exp Dermatol; 2015 Dec; 40(8):926-7. PubMed ID: 25266712
    [No Abstract]   [Full Text] [Related]  

  • 19. Imatinib-induced psoriasiform eruption in a patient with chronic myeloid leukemia.
    Shi CR; Nambudiri VE
    Am J Hematol; 2018 Mar; 93(3):467-468. PubMed ID: 28836284
    [No Abstract]   [Full Text] [Related]  

  • 20. Imatinib-induced pyoderma gangrenosum in a patient with chronic myeloid leukemia.
    Faraci AG; Genovese G; Ferrucci S; Marzano AV
    Indian J Dermatol Venereol Leprol; 2021; 87(5):704-706. PubMed ID: 34114414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.